Strados Labs Acquires Clinical Trial Business of NuvoAir, Delivering Full-Spectrum Respiratory Endpoint Solutions for Life Sciences

The acquisition brings together the gold standard for continuous ambulatory cough monitoring and lung sound analysis with proven remote spirometry and FeNO capabilities — creating a unique, single-partner endpoint solution for respiratory sponsors. PHILADELPHIA, PA — April 16, 2026 — Strados Labs, the respiratory endpoint intelligence company, today announced the acquisition of NuvoAir Clinical Trials […]

Strados Labs Announces Study Evaluating Remote Lung Sound Monitoring to Predict COPD Exacerbations

The SHORE study, in collaboration with Jefferson Health, will assess the feasibility of home-based, continuous monitoring of cough and lung sounds including wheeze and rhonchi following COPD exacerbations. Enrollment started in January. Philadelphia, PA, January 28th, 2026 — Strados Labs, a medical technology company advancing respiratory care through wearable technologies, today announced an observational research […]

Strados Labs Collaborates with Rutgers Robert Wood Johnson Medical School, RWJBarnabas Health to Evaluate Wearable Respiratory Monitoring in Cystic Fibrosis

The pilot study explores the RESP® Biosensor’s potential to allow for low-effort home monitoring in patients with acute and chronic cystic fibrosis. Philadelphia, PA, August 28th, 2025 — Strados Labs, a digital health company advancing respiratory health through wearable technologies, today announced a research collaboration with RWJBarnabas Health to evaluate its FDA 510(k) cleared RESP® […]

Strados Labs Accelerates Research into Continuous Lung Sound Monitoring in 2025

Philadelphia, PA, August 25, 2025. Strados Labs, a medical technology company focused on improving surveillance of respiratory diseases, is proud to announce a series of ongoing research collaborations in 2025 with leading academic institutions across the United States. These investigator-led studies aim to evaluate how continuous, objective respiratory monitoring with the RESP® Biosensor may improve […]

Strados Labs to Present Developments in Cough Monitoring at ATS 2025

Strados Labs looks forward to participating in the American Thoracic Society (ATS) 2025 International Conference from May 16–21 in San Francisco, CA. Please join us as we present sessions highlighting the importance of cough in respiratory diseases, along with new developments in cough monitoring technology. Strados Labs Featured Programs Tuning In To Cough in Pulmonary Fibrosis: How […]

Strados Labs Announces Partnership with Trialogics to Enhance Global Distribution to Clinical Trials 

Strados Labs, a medical technology company, is excited to announce a new partnership with Trialogics, a clinical trial software and logistics provider. This collaboration will leverage Trialogics’ comprehensive logistical expertise to streamline the distribution and delivery of Strados Labs’ RESP® Biosensors to clinical trial sites internationally. Strados Labs’ FDA-cleared RESP Biosensor continuously captures lung sounds […]

Announcing New Partnership with Delve Health

August 6, 2024 — Minneapolis, MN — Delve Health, a leader in decentralized clinical trial solutions, is excited to announce a strategic partnership with Strados Labs, an innovator in respiratory health technology. This collaboration aims to enhance remote patient monitoring capabilities in clinical trials, making research more accessible, accurate, and patient-centric. Advancing Remote Monitoring SolutionsDelve […]

Strados Labs announces successful completion of pediatric asthma study

Strados Labs, a digital health company focused on improving the lives of patients with respiratory diseases, announced today the successful completion of a recent study of its technology in pediatric asthma, which took place at Ann & Robert H. Lurie Children’s Hospital of Chicago. The study focused on evaluating the clinical utility and effectiveness of […]